---
title: "NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin"
ocid: "ocds-h6vhtk-04c141"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04c141"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04c141.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04c141.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2024-11-29"
---

# NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-04c141

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04c141)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04c141.json)

## Summary

NHS England has initiated a modification of an existing framework agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin. This procurement, initially valued at £1.2 billion, has been active since July 2021 and is now being extended until December 2025 to ensure the continuity of supply during a transitional period. The procurement category is goods, specifically immunoglobulins, with the contracting process at the award stage, involving the suppliers Bio Products Laboratory Ltd, CSL Behring UK Ltd, Grifols UK Ltd, and LFB Biopharmaceuticals Ltd. The framework's value is being increased to an estimated £1.6 billion due to higher demand and inflationary pressures.

This tender modification offers significant opportunities for businesses specialising in pharmaceutical supplies, particularly those involved in the production and distribution of immunoglobulins. Companies with robust capabilities in managing and transitioning pharmaceutical supplies will find substantial growth prospects in this framework. Key suppliers who can ensure reliable product delivery during the extended period will have an advantage, fostering partnerships with NHS England to contribute towards critical healthcare needs. The procurement method used is limited, without prior publication of a call for competition, indicating a bespoke and urgent requirement for continuity in patient care.

## Notice

NHS England has recently awarded a framework for Human Albumin & Normal and Anti-D Immunoglobulin

### Lot Information

Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)

5% Intravenous Immunoglobulin (5% IVIg)

Lot 2 - 10% Intravenous Immunoglobulin (10% IVIg)

10% Intravenous Immunoglobulin (10% IVIg)

Lot 3: Subcutaneous Immunoglobulin (SCIg)

Subcutaneous Immunoglobulin (SCIg)

Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)

5% Intravenous Immunoglobulin (5% IVIg)

Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)

10% Intravenous Immunoglobulin (10% IVIg)

Lot 7: Subcutaneous Immunoglobulin (SCIg)

Subcutaneous Immunoglobulin (SCIg)

### Procurement Information

Explanation provided in section VI.3. Additional information

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/038647-2024 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 29 Nov 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 22 Jun 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £400,000,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LONDON |
| Post town | South East London |
| Postcode | SE1 8UG |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 4 |
| Supplier names | BIO PRODUCTS LABORATORY; CSL BEHRING; GRIFOLS; LFB BIOPHARMACEUTICALS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651520 - Immunoglobulins

## Release History

- 29 Nov 2024 at 15:46 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/038647-2024

## Notice URLs

- https://www.cslbehring.co.uk/
- https://www.england.nhs.uk/
- https://www.grifols.com/en/home
- https://www.lfbbiopharmaceuticals.co.uk/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04c141. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04c141.json.